The Congressional Research Service has prepared a new account of the state secrets privilege, which is used by the government to bar disclosure of certain national security information in the course of civil litigation. While the CRS report contains nothing new, it is a detailed, dispassionate and fairly comprehensive account of the subject. A copy was obtained by Secrecy News. See “The State Secrets Privilege and Other Limits on Litigation Involving Classified Information” (pdf), May 28, 2009.
Other notable new CRS products that have not been made publicly available include the following (all pdf).
“Major U.S. Arms Sales and Grants to Pakistan Since 2001” (fact sheet), updated June 3, 2009.
“Political Turmoil in Thailand and U.S. Interests,” May 26, 2009.
“The 2009 Influenza A(H1N1) ‘Swine Flu’ Outbreak: An Overview,” May 20, 2009.
“Defense: FY2010 Authorization and Appropriations,” May 8, 2009.
“Medical Marijuana: Review and Analysis of Federal and State Policies,” March 31, 2009.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.
Inconsistent metrics and opaque reporting make future AI power‑demand estimates extremely uncertain, leaving grid planners in the dark and climate targets on the line